Last reviewed · How we verify

NCT04017000: BlaST

Bladder Shaper Test

Completed NA Last updated 22 June 2022
What this trial tests

NA trial testing Bladder Shape Test in Diagnosis of Urinary Tract Symptons in 156 participants. Completed in 31 January 2022.

Timeline
2 April 2019
Primary endpoint
31 January 2022
31 January 2022

Quick facts

Lead sponsorSheffield Teaching Hospitals NHS Foundation Trust
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingsingle
Primary purposediagnostic
Enrollment156
Start date2 April 2019
Primary completion31 January 2022
Estimated completion31 January 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Sheffield Teaching Hospitals NHS Foundation Trust

Who can join

18 and older, female only, with Diagnosis of Urinary Tract Symptons. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is comparing a novel method of Bladder shape measurements using ultrasound for diagnosis of lower urinary tract symptoms in comparison to traditional Urodynamic assessment. All participants will undergo the novel investigation followed by their usual Urodynamics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Sheffield Teaching Hospitals NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04017000.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing